These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Milnacipran for fibromyalgia: a useful addition to the treatment armamentarium. Bernstein CD; Albrecht KL; Marcus DA Expert Opin Pharmacother; 2013 May; 14(7):905-16. PubMed ID: 23506481 [TBL] [Abstract][Full Text] [Related]
7. Milnacipran for treatment of fibromyalgia. Kyle JA; Dugan BD; Testerman KK Ann Pharmacother; 2010 Sep; 44(9):1422-9. PubMed ID: 20716692 [TBL] [Abstract][Full Text] [Related]
8. Effect of Milnacipran Treatment on Ventricular Lactate in Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Trial. Natelson BH; Vu D; Mao X; Weiduschat N; Togo F; Lange G; Blate M; Kang G; Coplan JD; Shungu DC J Pain; 2015 Nov; 16(11):1211-9. PubMed ID: 26335989 [TBL] [Abstract][Full Text] [Related]
10. Pharmacology and pharmacokinetics of milnacipran. Puozzo C; Panconi E; Deprez D Int Clin Psychopharmacol; 2002 Jun; 17 Suppl 1():S25-35. PubMed ID: 12369608 [TBL] [Abstract][Full Text] [Related]
11. Current progress in the pharmacological therapy of fibromyalgia. Rao SG Expert Opin Investig Drugs; 2009 Oct; 18(10):1479-93. PubMed ID: 19732029 [TBL] [Abstract][Full Text] [Related]
12. Resting state connectivity correlates with drug and placebo response in fibromyalgia patients. Schmidt-Wilcke T; Ichesco E; Hampson JP; Kairys A; Peltier S; Harte S; Clauw DJ; Harris RE Neuroimage Clin; 2014; 6():252-61. PubMed ID: 25379438 [TBL] [Abstract][Full Text] [Related]
13. Milnacipran hydrochloride: its efficacy, safety and tolerability profile in fibromyalgia syndrome. Owen RT Drugs Today (Barc); 2008 Sep; 44(9):653-60. PubMed ID: 19137120 [TBL] [Abstract][Full Text] [Related]
14. Milnacipran, a new serotonin and noradrenaline reuptake inhibitor: an overview of its antidepressant activity and clinical tolerability. Puech A; Montgomery SA; Prost JF; Solles A; Briley M Int Clin Psychopharmacol; 1997 Mar; 12(2):99-108. PubMed ID: 9219045 [TBL] [Abstract][Full Text] [Related]
15. Milnacipran: beyond a role of antidepressant. Pae CU; Marks DM; Shah M; Han C; Ham BJ; Patkar AA; Masand PS Clin Neuropharmacol; 2009; 32(6):355-63. PubMed ID: 19620845 [TBL] [Abstract][Full Text] [Related]
16. Milnacipran (savella) for fibromyalgia. Med Lett Drugs Ther; 2009 Jun; 51(1314):45-6. PubMed ID: 19528885 [No Abstract] [Full Text] [Related]
17. Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms. Yoshida K; Takahashi H; Higuchi H; Kamata M; Ito K; Sato K; Naito S; Shimizu T; Itoh K; Inoue K; Suzuki T; Nemeroff CB Am J Psychiatry; 2004 Sep; 161(9):1575-80. PubMed ID: 15337646 [TBL] [Abstract][Full Text] [Related]
18. The monoamine-mediated antiallodynic effects of intrathecally administered milnacipran, a serotonin noradrenaline reuptake inhibitor, in a rat model of neuropathic pain. Obata H; Saito S; Koizuka S; Nishikawa K; Goto F Anesth Analg; 2005 May; 100(5):1406-1410. PubMed ID: 15845695 [TBL] [Abstract][Full Text] [Related]
19. Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clauw DJ; Mease P; Palmer RH; Gendreau RM; Wang Y Clin Ther; 2008 Nov; 30(11):1988-2004. PubMed ID: 19108787 [TBL] [Abstract][Full Text] [Related]
20. Milnacipran for neuropathic pain and fibromyalgia in adults. Derry S; Gill D; Phillips T; Moore RA Cochrane Database Syst Rev; 2012 Mar; 3(3):CD008244. PubMed ID: 22419330 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]